Related Experiment Video
Updated: Jul 13, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
[Dementia syndromes in the elderly: diagnostic procedures]
Sylvie Pariel-Madjlessi1, Cyril Opéron, Renaud Péquignot
1Service de gériatrie et consultation mémoire, Hôpital Charles Foix et Faculté de médecine Pierre et Marie Curie (Université Paris VI), Ivry-sur-Seine (94). sylvie.pariel@cfx.aphp.fr
Presse Medicale (Paris, France : 1983)
|July 14, 2007
Summary
Dementia involves cognitive decline affecting daily life, diagnosed through cognitive function evaluations. Early screening is crucial for timely diagnosis and management of this condition in the elderly.
Area of Science:
- Neurology
- Geriatrics
- Psychology
Background:
- Dementia is a cognitive decline impacting daily functioning, distinct from vigilance impairment.
- Symptoms include memory loss, functional autonomy loss, depression, and behavioral issues.
- Recognition can occur during routine screenings or clinical examinations.
Purpose of the Study:
- To highlight the importance of cognitive function evaluation in dementia diagnosis.
- To emphasize the necessity of causal investigations post-diagnosis for management.
- To address the need for early screening to improve recognition and diagnosis rates.
Main Methods:
- Initial assessment using simple physician-administered tests.
- Detailed cognitive evaluation by specialists or neuropsychologists when needed.
- Causal investigation to determine dementia's severity and extent.
Main Results:
- Cognitive evaluation is a critical diagnostic step.
- Simple tests offer a preliminary diagnostic approach.
- Specialist evaluation is often required for accurate diagnosis.
Conclusions:
- Prompt diagnosis and causal investigation are essential for effective dementia management.
- Screening for dementia in the elderly is vital for earlier detection.
- Addressing delayed diagnosis can improve patient outcomes.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...